Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Oral Cavity & Pharynx (Late Stage^), 2015-2019

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate ascending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank descending
Average Annual Count
 sort by count descending
Percent of Cases with Late Stage
 sort by percent late descending
US (SEER+NPCR) 1 7.4 (7.4, 7.5) N/A 29,392 62.7
West Virginia 6 9.6 (9.0, 10.1) 1 (1, 5) 240 68.8
Kentucky 3 9.2 (8.8, 9.5) 2 (1, 6) 513 66.9
Arkansas 6 8.9 (8.5, 9.3) 3 (1, 13) 330 62.8
Maine 6 8.9 (8.3, 9.5) 4 (1, 18) 173 63.9
Georgia 3 8.6 (8.4, 8.9) 5 (2, 12) 1,029 68.2
Vermont 6 8.5 (7.6, 9.4) 6 (1, 34) 73 68.5
Florida 6 8.4 (8.3, 8.6) 7 (4, 14) 2,459 60.6
Missouri 6 8.4 (8.1, 8.7) 8 (3, 18) 651 66.7
Tennessee 6 8.4 (8.1, 8.7) 9 (3, 19) 708 64.7
Iowa 3 8.3 (7.9, 8.8) 10 (3, 24) 328 58.5
Louisiana 3 8.3 (8.0, 8.7) 11 (3, 21) 467 64.7
North Carolina 6 8.3 (8.0, 8.5) 12 (5, 20) 1,056 66.0
Mississippi 6 8.2 (7.8, 8.6) 13 (3, 25) 301 64.4
Ohio 6 8.2 (8.0, 8.4) 14 (6, 20) 1,228 66.4
Indiana 6 8.1 (7.8, 8.4) 15 (6, 25) 652 64.1
Oregon 6 8.0 (7.7, 8.4) 16 (6, 28) 427 65.5
South Carolina 6 8.0 (7.7, 8.3) 17 (7, 27) 526 65.2
Pennsylvania 6 7.9 (7.7, 8.1) 18 (12, 26) 1,345 64.2
Wisconsin 6 7.9 (7.6, 8.2) 19 (10, 30) 595 63.7
Massachusetts 3 7.8 (7.5, 8.1) 20 (12, 29) 684 67.0
Illinois 3 7.8 (7.6, 8.0) 21 (14, 28) 1,209 64.6
Rhode Island 6 7.7 (7.1, 8.4) 22 (4, 40) 109 66.3
Delaware 6 7.7 (7.0, 8.4) 23 (4, 42) 100 62.6
Michigan 6 7.6 (7.4, 7.9) 24 (17, 31) 985 64.4
Hawaii 3 7.6 (7.0, 8.2) 25 (6, 40) 136 58.9
Connecticut 3 7.6 (7.2, 7.9) 26 (15, 36) 361 61.3
Oklahoma 6 7.4 (7.1, 7.8) 27 (17, 38) 345 57.2
Alaska 6 7.4 (6.5, 8.3) 28 (4, 47) 59 65.7
Nebraska 6 7.3 (6.8, 7.9) 29 (14, 44) 166 58.0
New Hampshire 6 7.3 (6.8, 7.9) 30 (13, 45) 139 62.1
Montana 6 7.3 (6.6, 8.0) 31 (10, 46) 103 61.6
Washington 5 7.2 (7.0, 7.5) 32 (23, 39) 647 59.0
New York 3 7.2 (7.0, 7.4) 33 (26, 38) 1,759 63.5
New Jersey 3 7.1 (6.9, 7.3) 34 (27, 41) 807 63.0
Kansas 6 7.1 (6.7, 7.5) 35 (23, 45) 247 60.2
Maryland 6 7.0 (6.7, 7.2) 36 (27, 44) 521 62.8
Idaho 3 6.9 (6.4, 7.4) 37 (22, 47) 143 56.7
Virginia 6 6.8 (6.6, 7.1) 38 (31, 45) 710 61.8
North Dakota 6 6.8 (6.0, 7.6) 39 (16, 48) 59 56.5
Alabama 6 6.8 (6.5, 7.1) 40 (30, 46) 421 53.6
District of Columbia 6 6.7 (5.9, 7.6) 41 (14, 49) 47 62.6
Texas 3 6.6 (6.5, 6.7) 42 (37, 46) 1,968 59.5
South Dakota 6 6.6 (5.9, 7.4) 43 (24, 49) 70 56.8
Minnesota 6 6.6 (6.3, 6.9) 44 (35, 47) 453 54.2
Colorado 6 6.5 (6.3, 6.8) 45 (35, 47) 425 61.2
California 3 6.5 (6.4, 6.6) 46 (40, 47) 2,888 63.9
Wyoming 6 5.9 (5.1, 6.8) 47 (33, 50) 42 56.3
Utah 3 5.8 (5.4, 6.2) 48 (45, 50) 162 58.3
New Mexico 3 5.5 (5.1, 5.9) 49 (46, 50) 144 61.7
Arizona 6 5.3 (5.1, 5.5) 50 (47, 50) 469 58.8
Puerto Rico 6 4.6 (4.3, 4.9) N/A 186 47.6
Nevada 6
data not available
N/A
data not available
data not available
Notes:
Created by statecancerprofiles.cancer.gov on 12/07/2022 8:31 am.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Nevada

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.

Source: SEER and NPCR data. For more specific information please see the table.

Interpret Rankings provides insight into interpreting cancer incidence statistics. When the population size for a denominator is small, the rates may be unstable. A rate is unstable when a small change in the numerator (e.g., only one or two additional cases) has a dramatic effect on the calculated rate.

Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top